The Risk of Cardiovascular Adverse Outcomes in Patients With Thymoma or Thymic Carcinoma Receiving Cancer Therapy
Year: 2025
Type: article
Language: en
Topic: Myasthenia Gravis and Thymoma
Authors and affiliations:
raw_author_name: Inbar Nardi Agmon
raw_affiliation_strings: Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Luna Jia Zhan
raw_affiliation_strings: Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada
Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Gloria Ho
raw_affiliation_strings: Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada
Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Farid Foroutan
raw_affiliation_strings: Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada
Rogers Computational Program, Ted Rogers Centre for Heart Research, Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Coleen Power
raw_affiliation_strings: Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Andrea Bezjak
raw_affiliation_strings: Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, Ontario, Canada
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Shaf Keshavjee
raw_affiliation_strings: Division of Thoracic Surgery, University of Toronto, Toronto General Hospital, Toronto, Ontario, Canada
raw_author_name: Oded Icht
raw_affiliation_strings: Gray Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, Ontario, Canada
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: John Miro
raw_affiliation_strings: Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada
Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Husam Abdel-Qadir
raw_affiliation_strings: Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada; Women's College Hospital (WCH), Toronto, Ontario, Canada
Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada; Women's College Hospital (WCH), Toronto, Ontario, Canada
raw_author_name: Andrew Hope
raw_affiliation_strings: Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, Ontario, Canada
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Liu Geoffrey
raw_affiliation_strings: Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada
Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON, Canada
raw_author_name: Paaladinesh Thavendiranathan
raw_affiliation_strings: Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: dinesh.thavendiranathan@uhn.ca
Department of Medicine, Division of Cardiology, Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: dinesh.thavendiranathan@uhn.ca